Patents Assigned to SciClone Pharmaceticals, Inc.
  • TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES
    Publication number: 20100197595
    Abstract: A method of treating melanoma or a metastasis thereof in a human patient by administering a melanoma-treating effective amount of an alpha thymosin peptide to a human melanoma patient, wherein the human melanoma patient does not have a substantially elevated LDH blood level.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 5, 2010
    Applicant: Sciclone Pharmaceticals, Inc.
    Inventors: Cynthia W. Tuthill, Israel Rios
  • Methods of protecting against radiation damage using alpha thymosin
    Publication number: 20060166877
    Abstract: Damage to cells and/or a subject caused by radiation is treated or prevented by administration of an alpha thymosin peptide.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 27, 2006
    Applicant: SciClone Pharmaceticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill